M Gao, M Callari, E Beddowes, S-J Sammut, M Grzelak, H Biggs, L Jones, A Boumertit, SC Linn, J Cortes, M Oliveira, R Baird, S-F Chin, C Caldas
Journal name: 
Genome Med
Citation info: 
Circulating tumour DNA (ctDNA) detection and monitoring have enormous potential clinical utility in oncology. We describe here a fast, flexible and cost-effective method to profile multiple genes simultaneously in low input cell-free DNA (cfDNA): Next Generation-Targeted Amplicon Sequencing (NG-TAS). We designed a panel of 377 amplicons spanning 20 cancer genes and tested the NG-TAS pipeline using cell-free DNA from two HapMap lymphoblastoid cell lines. NG-TAS consistently detected mutations in cfDNA when mutation allele fraction was > 1%. We applied NG-TAS to a clinical cohort of metastatic breast cancer patients, demonstrating its potential in monitoring the disease. The computational pipeline is available at .
Research group: 
Caldas Group
E-pub date: 
31 Dec 2018
Users with this publication listed: 
Carlos Caldas
Emma Beddowes
Richard Baird
Stephen-John Sammut
Suet-Feung Chin